Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma.

Cancer cell·2026
Same author

Long-term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma.

BJUI compass·2026
Same author

Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.

Cancers·2025
Same author

Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center Experience.

Clinical genitourinary cancer·2025
Same author

Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.

European urology oncology·2025
Same author

MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma.

European urology·2025

Related Experiment Video

Updated: Apr 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

Open mini-flank partial nephrectomy: an essential contemporary operation.

Paul Russo1, Roy Mano1

  • 1Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Korean Journal of Urology
|September 20, 2014
PubMed
Summary
This summary is machine-generated.

Partial nephrectomy (PN) is now preferred for small renal tumors, offering equivalent survival to radical nephrectomy (RN) while preserving kidney function. This approach is crucial for managing incidentally detected tumors and preventing chronic kidney disease.

Keywords:
Chronic kidney failureMethodsNephrectomy

More Related Videos

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K
Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

56.0K

Related Experiment Videos

Last Updated: Apr 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K
Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

56.0K

Area of Science:

  • Urology
  • Nephrology
  • Surgical Oncology

Background:

  • Modern imaging techniques lead to incidental detection of renal tumors in 70% of cases, often small (median < 4 cm).
  • Historically, radical nephrectomy (RN) was the standard treatment for all renal tumors, regardless of size.
  • Partial nephrectomy (PN) has become the preferred treatment for small renal tumors due to evolving clinical evidence and patient benefits.

Purpose of the Study:

  • To highlight the paradigm shift in renal tumor treatment from RN to PN for small tumors.
  • To explain the key factors supporting the adoption of PN as the treatment of choice.
  • To introduce a novel surgical approach for PN with enhanced recovery.

Main Methods:

  • Comparative analysis of cancer-specific survival rates for PN versus RN in T1 tumors.
  • Review of renal tumor pathology to determine the prevalence of indolent or benign conditions.
  • Evaluation of the impact of PN on the onset and progression of chronic kidney disease.
  • Description of a minimally invasive "mini-flank" open surgical approach for PN.

Main Results:

  • Cancer-specific survival is equivalent for T1 tumors (≤7 cm) treated with either PN or RN.
  • Approximately 45% of renal tumors exhibit indolent or benign pathology, supporting conservative management.
  • PN effectively prevents or delays chronic kidney disease, mitigating associated cardiovascular risks.
  • The "mini-flank" approach facilitates rapid recovery with a 2-day hospital stay.

Conclusions:

  • Partial nephrectomy is the recommended treatment for small renal tumors, offering oncologic equivalence to radical nephrectomy with superior renal function preservation.
  • The benefits of PN, including reduced risk of chronic kidney disease and cardiovascular complications, outweigh the technical challenges and potential risks.
  • The developed "mini-flank" surgical technique combined with accelerated recovery protocols enhances patient outcomes and hospital efficiency for renal tumor management.